Crispr Therapeutics AG(DE:1CG)
€37.97-0.40 (-1.04%)
DE:1CG
Crispr Therapeutics AG earnings date
€37.97
At close:-0.40 (-1.04%)
Crispr Therapeutics AG (1CG) Q2 2023 Earnings Report
22 Followers
DE:1CG Q2 2023 EPS Results
- Actual EPS
- -EUR 0.88
- Consensus EPS
- -EUR 1.90
- Beat/Miss
- Beat by +EUR 1.03
- One Year Ago EPS
- -EUR 2.15
DE:1CG Q2 2023 Revenue Results
- Actual Revenue
- EUR 62.67M
- Expected Revenue
- EUR 1.61M
- Beat/Miss
- Beat by +EUR 61.06M
- YoY Revenue Growth
- +44203.80%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/07/2023
- Time
- After Close
- Conference Call
- Monday, August 7, 2023
DE:1CG Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1CG Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | -1.05- | -1.23 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.93-1.03 | -1.05 | 1.71% (+0.02) | |
| Aug 03, 2026 | 2026 (Q2) | -1.07-0.84 | -2.15 | 60.83% (+1.31) | |
| May 04, 2026 | 2026 (Q1) | -1.09-1.15 | -1.41 | 18.99% (+0.27) | |
| Feb 12, 2026 | 2025 (Q4) | -1.04-1.23 | -0.39 | -211.36% (-0.83) | |
| Nov 10, 2025 | 2025 (Q3) | -1.13-1.05 | -0.9 | -15.84% (-0.14) | |
| Aug 04, 2025 | 2025 (Q2) | -1.26-2.15 | -1.33 | -61.07% (-0.81) | |
| May 06, 2025 | 2025 (Q1) | -1.11-1.41 | -1.28 | -10.49% (-0.13) | |
| Feb 11, 2025 | 2024 (Q4) | -1.08-0.39 | 0.98 | -140.00% (-1.38) | |
| Nov 05, 2024 | 2024 (Q3) | -1.26-0.90 | -1.26 | 28.37% (+0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

